Literature DB >> 10206588

Corneal toxicity associated with latanoprost.

S Sudesh1, E J Cohen, C J Rapuano, R P Wilson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10206588     DOI： 10.1001/archopht.117.4.539

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN： 0003-9950


× No keyword cloud information.
  6 in total

Review 1.  Effects of common topical antiglaucoma medications on the ocular surface, eyelids and periorbital tissue.

Authors:  J Javier Servat; C Robert Bernardino
Journal:  Drugs Aging       Date:  2011-04-01       Impact factor: 3.923

2.  Netarsudil-Induced Corneal Flattening in a Child with Secondary Open-Angle Glaucoma.

Authors:  Durga Ganesh; Anne L Coleman; Vivian P Shibayama; Victoria L Tseng
Journal:  Case Rep Ophthalmol       Date:  2022-05-02

Review 3.  Latanoprost : an update of its use in glaucoma and ocular hypertension.

Authors:  Caroline M Perry; Jane K McGavin; Christine R Culy; Tim Ibbotson
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

Review 4.  A Narrative Review of Ocular Surface Disease Related to Anti-Glaucomatous Medications.

Authors:  Xiaoyu Zhou; Xinyue Zhang; Dengming Zhou; Yang Zhao; Xuanchu Duan
Journal:  Ophthalmol Ther       Date:  2022-08-09

5.  A patient with corneal epithelial disorder that developed after administration of a latanoprost generic, but not a brand-name drug, eye drop.

Authors:  Yukihisa Takada; Yuka Okada; Norihito Fujita; Shizuya Saika
Journal:  Case Rep Ophthalmol Med       Date:  2012-10-02

6.  Anti-glaucoma agents-induced pseudodendritic keratitis presumed to be herpetic simplex keratitis: a clinical case series.

Authors:  Huai-Lung Chang; Bo-I Kuo; Jo-Hsuan Wu; Wei-Lun Huang; Chien-Chia Su; Wei-Li Chen
Journal:  Sci Rep       Date:  2021-11-02       Impact factor: 4.379
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.